Accelerator Entry: REOFTech accepted into Gen.1 of BioLeap and EC-Safety accepted into Pre18
The company was accepted into two accelerator programs within Puerto Rico.
Patent Awarded: US 12 167 919 B2 – System and method for non-invasive, intracranial brain motion monitoring
The underlying technology and methodology for the pilot funded device, NINscan, was awarded a patent in December 2024. Source: US 12,167,919 B2 (patentsgazette.uspto.gov)
Publication: Predicting Orthostatic Symptoms Using a Multiparameter Wearable Sensor
Authors: Ziad A Elhajjaji, Amar S Basu Abstract Orthostatic disorders affect 30% of older adults and increase the risk for falls. The current diagnostic standard, the blood pressure cuff, cannot capture the rapid, multifaceted dynamics of orthostasis physiology, resulting in frequent underdiagnosis. This paper demonstrates multiparameter, real-time measurement of orthostasis using TRACE, an earlobe mounted wearable developed in our group. In prior work, we demonstrated a novel metric called orthostatic hypovolemia (OHV1), the initial loss in cephalic (head) blood volume immediately upon standing. This study significantly advances our prior work by introducing an additional 2 metrics: OHV2, the cephalic blood volume deficit after the body achieves homeostasis after standing; and postural orthostatic tachycardia (POT), the increase in heart rate. The 3 metrics were evaluated in 101 older adults who wore the TRACE device during postural…
Past Webinar – Practical Cognitive Assessment Methods for AD/ADRD Research Projects
https://youtu.be/4weOZ9Tf-Og?si=lzfkLGsUZVZSseRz Abstract: This webinar will examine cognitive assessment methods in Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) research, featuring insights from neuropsychology, geriatric psychiatry, and digital health technology. Panelists will highlight the challenges of accurate screening across diverse populations and settings, from community-based studies to clinical trials. Presentations will explore traditional tools like the MoCA and CDR alongside emerging digital approaches using speech AI, wearable sensors, and web-based platforms. Discussions will emphasize demographic influences, functional measures, and resource considerations in selecting appropriate screening strategies. Case studies will illustrate lessons learned in real-world pilot projects, including practice effects, scalability barriers, and the integration of cognitive and functional assessments.Attendees will gain a nuanced understanding of current and future cognitive screening tools and how to apply them effectively in research and clinical contexts. About the Speakers: Kathryn…
Grant Funding: NIH Trailblazer Award
This is an R21 award for $650,000 over a period of 3 years. Their smartphone app prototype capitalizes on the handheld nature of a mobile phone and uses its built-in sensors to gauge grip strength to enhance preoperative screening for potential risks of complications post cardiac surgery. This effort will contribute to the growing portfolio of smartphone-based health monitoring solutions actively being developed by Wang and his research team. Source: https://today.ucsd.edu/story/uc-san-diego-researcher-receives-nih-trailblazer-award
Oral Presentation: American Speech Language Hearing Association Conference – 2024
Presented " Quality Management Framework for an Automated, Phone-Based Telehealth Platform for Cognitive Rehabilitation Therapy" at the ASHA Conference in Seattle, WA on November 11, 2024 Source: https://plan.core-apps.com/asha2024/event/6a3d638ef5896a352b49fbfd8b5f1248
Past Webinar – Unlocking Success: FDA Regulatory Strategies for AgeTech Devices and AI
https://www.youtube.com/watch?v=0dpRR_cDPPs Abstract: This webinar explores regulatory strategies for bringing AgeTech devices and AI innovations to market under FDA oversight. Panelists provided an overview of FDA pathways, including 510(k), De Novo, and Pre-Market Approval (PMA), highlighting how device classification and intended use shape regulatory requirements. Discussion emphasized unique challenges for software as a medical device (SaMD), clinical decision support (CDS) tools, and AI/ML-enabled technologies, including validation standards and cybersecurity mandates. Speakers underscored the importance of aligning regulatory strategy with business models and offered guidance on leveraging Pre-Submission processes and breakthrough device designation to accelerate approval. Real-world insights from wearable device development illustrated the complexities of clinical validation, reimbursement planning, and risk-based regulation.You will gain practical knowledge on navigating FDA processes to responsibly develop and deploy AgeTech innovations for older adults. About the Speakers: Ameet Sarpatwari, PhD,…
- Go to the previous page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- …
- 42
- Go to the next page